Literature DB >> 10756040

The use of chimeric Venezuelan equine encephalitis viruses as an approach for the molecular identification of natural virulence determinants.

A M Powers1, A C Brault, R M Kinney, S C Weaver.   

Abstract

Venezuelan equine encephalitis (VEE) virus antigenic subtypes and varieties are considered either epidemic/epizootic or enzootic. In addition to epidemiological differences between the epidemic and enzootic viruses, several in vitro and in vivo laboratory markers distinguishing the viruses have been identified, including differential plaque size, sensitivity to interferon (IFN), and virulence for guinea pigs. These observations have been shown to be useful predictors of natural, equine virulence and epizootic potential. Chimeric viruses containing variety IAB (epizootic) nonstructural genes with variety IE (enzootic) structural genes (VE/IAB-IE) or IE nonstructural genes and IAB structural genes (IE/IAB) were constructed to systematically analyze and map viral phenotype and virulence determinants. Plaque size analysis showed that both chimeric viruses produced a mean plaque diameter that was intermediate between those of the parental strains. Additionally, both chimeric viruses showed intermediate levels of virus replication and virulence for guinea pigs compared to the parental strains. However, IE/IAB produced a slightly higher viremia and an average survival time 2 days shorter than the VE/IAB-IE virus. Finally, IFN sensitivity assays revealed that only one chimera, VE/IAB-IE, was intermediate between the two parental types. The second chimera, containing the IE nonstructural genes, was at least five times more sensitive to IFN than the IE parental virus and greater than 50 times more sensitive than the IAB parent. These results implicate viral components in both the structural and nonstructural portions of the genome in contributing to the epizootic phenotype and indicate the potential for epidemic emergence from the IE enzootic VEE viruses.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10756040      PMCID: PMC111942          DOI: 10.1128/jvi.74.9.4258-4263.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Protein-protein interactions in an alphavirus membrane.

Authors:  R P Anthony; D T Brown
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

2.  Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis virus: construction of single and multiple mutants in a full-length cDNA clone.

Authors:  N L Davis; N Powell; G F Greenwald; L V Willis; B J Johnson; J F Smith; R E Johnston
Journal:  Virology       Date:  1991-07       Impact factor: 3.616

3.  An outbreak of Venezuelan equine encephalomeylitis in Central America. Evidence for exogenous source of a virulent virus subtype.

Authors:  P T Franck; K M Johnson
Journal:  Am J Epidemiol       Date:  1971-11       Impact factor: 4.897

4.  Antigenic variants of Venezuelan equine encephalitis virus: their geographic distribution and epidemiologic significance.

Authors:  N A Young; K M Johnson
Journal:  Am J Epidemiol       Date:  1969-03       Impact factor: 4.897

5.  Repeated emergence of epidemic/epizootic Venezuelan equine encephalitis from a single genotype of enzootic subtype ID virus.

Authors:  A M Powers; M S Oberste; A C Brault; R Rico-Hesse; S M Schmura; J F Smith; W Kang; W P Sweeney; S C Weaver
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

6.  Western equine encephalitis virus is a recombinant virus.

Authors:  C S Hahn; S Lustig; E G Strauss; J H Strauss
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

7.  A single amino acid change in the E2 glycoprotein of Venezuelan equine encephalitis virus affects replication and dissemination in Aedes aegypti mosquitoes.

Authors:  T M Woodward; B R Miller; B J Beaty; D W Trent; J T Roehrig
Journal:  J Gen Virol       Date:  1991-10       Impact factor: 3.891

8.  Epidemiological significance of Venezuelan equine encephalomyelitis virus in vitro markers.

Authors:  D H Martin; W H Dietz; O Alvaerez; K M Johnson
Journal:  Am J Trop Med Hyg       Date:  1982-05       Impact factor: 2.345

9.  The full-length nucleotide sequences of the virulent Trinidad donkey strain of Venezuelan equine encephalitis virus and its attenuated vaccine derivative, strain TC-83.

Authors:  R M Kinney; B J Johnson; J B Welch; K R Tsuchiya; D W Trent
Journal:  Virology       Date:  1989-05       Impact factor: 3.616

10.  Phylogenetic analysis of alphaviruses in the Venezuelan equine encephalitis complex and identification of the source of epizootic viruses.

Authors:  S C Weaver; L A Bellew; R Rico-Hesse
Journal:  Virology       Date:  1992-11       Impact factor: 3.616

View more
  21 in total

1.  Envelope glycoprotein mutations mediate equine amplification and virulence of epizootic venezuelan equine encephalitis virus.

Authors:  Ivorlyne P Greene; Slobodan Paessler; Laura Austgen; Michael Anishchenko; Aaron C Brault; Richard A Bowen; Scott C Weaver
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

2.  Positively charged amino acid substitutions in the e2 envelope glycoprotein are associated with the emergence of venezuelan equine encephalitis virus.

Authors:  Aaron C Brault; Ann M Powers; Edward C Holmes; C H Woelk; Scott C Weaver
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

3.  Role of alpha/beta interferon in Venezuelan equine encephalitis virus pathogenesis: effect of an attenuating mutation in the 5' untranslated region.

Authors:  L J White; J G Wang; N L Davis; R E Johnston
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

4.  Venezuelan equine encephalitis in Panama: fatal endemic disease and genetic diversity of etiologic viral strains.

Authors:  Evelia Quiroz; Patricia V Aguilar; Julio Cisneros; Robert B Tesh; Scott C Weaver
Journal:  PLoS Negl Trop Dis       Date:  2009-06-30

5.  Structural and nonstructural protein genome regions of eastern equine encephalitis virus are determinants of interferon sensitivity and murine virulence.

Authors:  Patricia V Aguilar; A Paige Adams; Eryu Wang; Wenli Kang; Anne-Sophie Carrara; Michael Anishchenko; Ilya Frolov; Scott C Weaver
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

6.  Venezuelan equine encephalitis emergence: enhanced vector infection from a single amino acid substitution in the envelope glycoprotein.

Authors:  Aaron C Brault; Ann M Powers; Diana Ortiz; Jose G Estrada-Franco; Roberto Navarro-Lopez; Scott C Weaver
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-26       Impact factor: 11.205

7.  IRES-based Venezuelan equine encephalitis vaccine candidate elicits protective immunity in mice.

Authors:  Shannan L Rossi; Mathilde Guerbois; Rodion Gorchakov; Kenneth S Plante; Naomi L Forrester; Scott C Weaver
Journal:  Virology       Date:  2013-01-22       Impact factor: 3.616

8.  Venezuelan equine encephalitis virus in the mosquito vector Aedes taeniorhynchus: infection initiated by a small number of susceptible epithelial cells and a population bottleneck.

Authors:  Darci R Smith; A Paige Adams; Joan L Kenney; Eryu Wang; Scott C Weaver
Journal:  Virology       Date:  2007-11-19       Impact factor: 3.616

9.  Common marmosets (Callithrix jacchus) as a nonhuman primate model to assess the virulence of eastern equine encephalitis virus strains.

Authors:  A Paige Adams; Judith F Aronson; Suzette D Tardif; Jean L Patterson; Kathleen M Brasky; Robert Geiger; Melissa de la Garza; Ricardo Carrion; Scott C Weaver
Journal:  J Virol       Date:  2008-07-09       Impact factor: 5.103

10.  Venezuelan equine encephalitis virus infection of cotton rats.

Authors:  Anne-Sophie Carrara; Lark L Coffey; Patricia V Aguilar; Abelardo C Moncayo; Amelia P A Travassos Da Rosa; Marcio R T Nunes; Robert B Tesh; Scott C Weaver
Journal:  Emerg Infect Dis       Date:  2007-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.